Compare BVS & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BVS | MLAB |
|---|---|---|
| Founded | 2011 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.9M | 489.8M |
| IPO Year | 2016 | 1995 |
| Metric | BVS | MLAB |
|---|---|---|
| Price | $8.94 | $80.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $14.25 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 299.8K | 87.3K |
| Earning Date | 06-15-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.87% |
| EPS Growth | ★ 163.46 | 99.24 |
| EPS | 0.33 | ★ 1.95 |
| Revenue | ★ $568,087,000.00 | N/A |
| Revenue This Year | $7.42 | $6.07 |
| Revenue Next Year | $6.46 | $5.41 |
| P/E Ratio | ★ $26.74 | $37.85 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.81 | $59.63 |
| 52 Week High | $10.13 | $130.12 |
| Indicator | BVS | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 58.54 | 38.33 |
| Support Level | $6.42 | $77.23 |
| Resistance Level | $9.01 | $81.62 |
| Average True Range (ATR) | 0.39 | 4.18 |
| MACD | -0.02 | -1.95 |
| Stochastic Oscillator | 54.07 | 36.49 |
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.